T1D Autoantibody Panel

About Enable Biosciences

Enable Biosciences is a private, commercial-stage diagnostics company developing advanced antibody detection tests for predictive medicine. Its core technology, ADAP, enables highly accurate screening for autoantibodies associated with type 1 diabetes, allowing for early risk assessment years before clinical onset. The company has validated its platform through significant partnerships and government grants, is actively commercializing its T1D test, and is exploring applications in other autoimmune conditions. Its business model is centered on providing diagnostic testing services and kits to healthcare providers and researchers.

Therapeutic Areas